Cafepharma Today

May 27 2025 - Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Rocket crashes as gene therapy patient dies, FDA imposes hold
Biogen maps out $1B biobucks deal with RNAi-focused City Therapeutics
Trump taps Oz to lead drug pricing negotiations as customs warns against import violations
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Earnings Preview: King Pharmaceuticals
Seeking Alpha
Wednesday, November 4, 2009 - 2:45pm
tags:
King, earnings
Drugmakers find whistle-blowing a bitter pill to swallow
APP.com
Wednesday, November 4, 2009 - 11:36am
tags:
whistleblowers
Merck, Schering-Plough debut today as one company
Newark Star-Ledger, NJ
Wednesday, November 4, 2009 - 11:34am
tags:
Merck, Schering Plough, M&A, reorganization
How To Market A Drug Off Label
Pharmalot
Wednesday, November 4, 2009 - 11:32am
tags:
off-label
Merck, Pfizer, J&J lead drug stocks higher
Marketwatch
Wednesday, November 4, 2009 - 11:31am
tags:
JNJ, Pfizer, Merck, drug stocks
Top 10 Blockbuster Biotech Drugs
Fierce Biotech
Wednesday, November 4, 2009 - 9:09am
tags:
biotech
Omnicare & Ivax Pay $112M Over Kickback Charges
Pharmalot
Wednesday, November 4, 2009 - 9:03am
tags:
kickbacks, Omnicare, Ivax Diagnostics, DOJ
Big Pharma Again Taking Shot At Vaccines
Yahoo/Investors Business Daily
Wednesday, November 4, 2009 - 9:02am
tags:
vaccines, AstraZeneca, Abbott Laboratories, Dendreon
Merck, now the world's No. 2 drugmaker with Schering-Plough purchase, set for future deals
Yahoo/AP
Wednesday, November 4, 2009 - 8:54am
tags:
Merck, M&A, Schering Plough
Novartis to buy 85% of Chinese vaccines producer
Marketwatch
Wednesday, November 4, 2009 - 8:53am
tags:
Novartis, vaccines, M&A, China, Zhejiang Tianyuan Bio-Pharmaceutical
Novartis Seeks to Make China One of Its Top Three Global Markets
Seeking Alpha
Wednesday, November 4, 2009 - 8:52am
tags:
Novartis, China
Two Healthcare Favorites: HMSY,TEVA
Seeking Alpha
Wednesday, November 4, 2009 - 8:49am
tags:
Teva Pharmaceuticals, PBMs, HMS Holdings
A Little Distracted, Are You, Merck?
Motley Fool
Wednesday, November 4, 2009 - 8:48am
tags:
Merck, FDA
Impax swings to Q3 profit
Bizjournals.com
Wednesday, November 4, 2009 - 8:43am
tags:
Impax, earnings
Cramer Finds Catalyst for Celgene’s Stock
CNBC
Wednesday, November 4, 2009 - 8:42am
tags:
Celgene, Revlimid
Breast Cancer Vaccine Tests German Merck’s $1 Billion Strategy
Bloomberg
Wednesday, November 4, 2009 - 8:41am
tags:
Merck KGaA, vaccines, breast cancer, Stimuvax
Medco Earnings Rise 13% on Increased Demand for Prescription Medicines
Bloomberg
Wednesday, November 4, 2009 - 8:40am
tags:
Medco, earnings, PBMs
The real meaning of J&J’s layoffs
Fortune
Wednesday, November 4, 2009 - 8:25am
tags:
JNJ, layoffs
Amylin Scores a Hat Trick
Motley Fool
Tuesday, November 3, 2009 - 4:23pm
tags:
Amylin, Eli Lilly, Byetta, diabetes
Merck, Schering-Plough to complete merger Tuesday
Marketwatch
Tuesday, November 3, 2009 - 12:08pm
tags:
M&A, Merck, Schering Plough

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.